Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines

Effectiveness Analysis ◽

Diabetes Nephropathy

The involvement of physician assistants in inpatient care in hospitals in the Netherlands: a cost-effectiveness analysis

BMJ Open ◽

10.1136/bmjopen-2017-016405 ◽

2017 ◽

Vol 7 (7) ◽

pp. e016405 ◽

Cited By ~ 8

Author(s):

Marijke J C Timmermans ◽

Geert T van den Brink ◽

Anneke J A H van Vught ◽

Eddy Adang ◽

Charles L H van Berlo ◽

...

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

Inpatient Care ◽

Physician Assistants ◽

BLOOD DONORS AND BLOOD COLLECTION: Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands

Transfusion ◽

10.1111/j.1537-2995.2009.02351.x ◽

2009 ◽

Vol 49 (12) ◽

pp. 2729-2742 ◽

Cited By ~ 25

Author(s):

Marinus Van Hulst ◽

Gijs A.A. Hubben ◽

Kwamena W.C. Sagoe ◽

Charupon Promwong ◽

Parichart Permpikul ◽

...

Keyword(s):

Risk Assessment ◽

Cost Effectiveness ◽

The Netherlands ◽

Blood Donors ◽

Global Model ◽

Transmission Risk ◽

Blood Collection ◽

Web Interface ◽

PIN65 COST-EFFECTIVENESS ANALYSIS ON ELDERLY PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS: CHALLENGING THE DUTCH HEALTH COUNCIL'S ADVICE

Value in Health ◽

10.1016/j.jval.2019.09.1306 ◽

2019 ◽

Vol 22 ◽

pp. S650

Author(s):

F. Zeevat ◽

W.G. Boersma ◽

J. van der Schans ◽

C. Boersma ◽

M. Postma

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

Pneumococcal Vaccination ◽

Effectiveness Analysis ◽

Dutch Health

Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

BMJ Open Diabetes Research & Care ◽

10.1136/bmjdrc-2019-000705corr1 ◽

2020 ◽

Vol 8 (1) ◽

pp. e000705corr1

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

The Netherlands ◽

Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

Value in Health ◽

10.1016/j.jval.2013.08.286 ◽

2013 ◽

Vol 16 (7) ◽

pp. A372

Author(s):

M.K. Langenfeld ◽

S. Visser

Keyword(s):

Respiratory Syncytial Virus ◽

Cost Effectiveness ◽

High Risk ◽

The Netherlands ◽

Preterm Infants ◽

Late Preterm Infants ◽

Effectiveness Analysis ◽

Rsv Infection ◽

Syncytial Virus

Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands

Vaccine ◽

10.1016/j.vaccine.2016.10.019 ◽

2016 ◽

Vol 34 (50) ◽

pp. 6381-6387 ◽

Cited By ~ 2

Author(s):

Jos Luttjeboer ◽

Didik Setiawan ◽

Qi Cao ◽

Toos CAHH Daemen ◽

Maarten J. Postma

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

Cervical Intraepithelial Neoplasia ◽

Therapeutic Vaccine ◽

Intraepithelial Neoplasia ◽

Hpv 16 ◽

PMS26 COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN THE TREATMENT OF OPENTIBIA FRACTURES IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)66795-2 ◽

2008 ◽

Vol 11 (6) ◽

pp. A544

Author(s):

M Van Genugten ◽

A Chhabra ◽

V Alt

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

CV4 COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN STABLE ANGINA PATIENTS IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)66188-8 ◽

2008 ◽

Vol 11 (6) ◽

pp. A342-A343

Author(s):

MJ Nuijten ◽

WK Redekop

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

Stable Angina ◽

Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands

Journal of Medical Economics ◽

10.1080/13696998.2017.1331912 ◽

2017 ◽

Vol 20 (8) ◽

pp. 813-824 ◽

Cited By ~ 9

Author(s):

Marieke Heisen ◽

Maarten J. Treur ◽

Harald E. Heemstra ◽

Eric B. W. Giesen ◽

Maarten J. Postma

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

The Netherlands ◽

Secondary Prevention ◽

PHC5 A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN THE NETHERLANDS

Value in Health ◽

10.1016/s1098-3015(10)66759-9 ◽

2008 ◽

Vol 11 (6) ◽

pp. A532-A533

Author(s):

M Van Genugten ◽

A Chhabra ◽

V Alt

Keyword(s):

Cost Effectiveness ◽

The Netherlands ◽

Spine Fusion ◽

Fusion Surgery ◽